Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01572974 · ClinicalTrials.gov registry record
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease
A clinical trial, sponsored by Midwest Biomedical Research Foundation.
- Terminated
- Registry status
- 89
- Enrollment target
NCT01572974: Clinical Trial study, sponsored by Midwest Biomedical Research Foundation.
NCT01572974 is a clinical trial that was terminated before completion, run by Midwest Biomedical Research Foundation. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01572974 was terminated before completion, sponsored by Midwest Biomedical Research Foundation.
- TERMINATED
- Registry status
- 89 participants
- Enrollment target
Study Summary
To Compare the overall quality of life of patients with no Barrett's esophagus , non-dysplastic Barrett's Esophagus (NDBE), Barrett's esophagus with low grade dysplasia (LGD), and Barrett's esophagus with high grade dysplasia (HGD). We also Compare the overall quality of life of Barrett's esophagus patients with severe gastroesophageal reflux disease (GERD) symptoms to those with no GERD symptoms
Primary Outcome
questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2010-01 |
| Est. Completion | 2017-12 |
Why NCT01572974 stopped before completion
NCT01572974 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01572974 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01572974 about?
NCT01572974 is a clinical study titled "Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease". To Compare the overall quality of life of patients with no Barrett's esophagus , non-dysplastic Barrett's Esophagus (NDBE), Barrett's esophagus with low grade dysplasia (LGD), and Barrett's esophagus with high grade dysplasia (HGD). We also Compare the overall quality of life of Barrett's esophagus ...
What is the current status of trial NCT01572974?
This trial is currently terminated. The enrollment target is 89 participants. The study started on 2010-01. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT01572974?
This trial is sponsored by Midwest Biomedical Research Foundation, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia